This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Press and hold the button
If you believe this is an error, please contact our support team.
192.64.82.12 : 9e1f99a2-6c4a-4008-ba15-1c3b7afb
Machine learning models can reliably inform clinicians about the disability progression of multiple sclerosis, according to a new study published this week in the open-access journal PLOS Digital Health by
Just a moment… Enable JavaScript and cookies to continue This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until
Credit: Pixabay/CC0 Public Domain The safety and effectiveness of donanemab—an Alzheimer’s drug recently approved by the US Food & Drug Administration (FDA)—is called into question in an investigation published by
